Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Human gene therapy. Clinical development - United States
doi 10.1089/humc.2015.164
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2016
Authors
Publisher
Mary Ann Liebert Inc